HEALTH & LIFE SCIENCE COLLABORATION & INNOVATION EXECUTIVE ROUNDTABLE SUMMARY DOCUMENT ENTERPRISE & INNOVATION - THE INSTITUTE OF LIFE SCEINCE www.swansea.ac.uk/medicine/ilsinnovation Continuing Excellence: Strategy for Growth 1
CONTENTS Title Page Introduction 0 1 Objectives 2 Our Rankings and Partners 3 Keynote Summary 4-5- 6 Follow Up 6-7 Outcomes 8 Enterprise and Innovation Team 9 INTRODUCTION Swansea University Medical School hosted an Executive Round Table event at their Institute of Life Science 2 (ILS2) building to explore the opportunities and challenges in innovation and collaboration in health and life science across the South West Wales region and beyond. This executive summary report outlines the comments from the 6 working groups. Attended by 44 delegates, the roundtable was co-sponsored by Fujitsu, Siemens, Swansea University Medical School, Swansea University s School of Management and chaired by Helen Mary Jones, Deputy Director of the Morgan Academy. Delegates were split into 6 working groups to further explore themes introduced by the events keynote speakers. Participating delegates and keynote speakers represented a range of expertise and sectors across the region, including fields such as; technology, engineering, communication, biopharmaceuticals, regional NHS partners and organisations. The Executive Round Table event delivered a highly stimulating debate by virtue of the nature of attendees and the excellent facilitation of discussions. The attendees were highly engaged and clearly included a range of thought leaders and change agents. - MR PETER HARRISON Managing Director of Siemens Healthineers, Siemens 0
INSTITUTE OF LIFE SCIENCE The (ILS) is the research, enterprise and innovation arm of Swansea University Medical School. Valued at 100 million, the ILS is Wales premier purpose-built medical research facility and is a collaboration between Swansea University, the Welsh Government, Abertawe Bro Morgannwg University (ABMU) Health Board, and industry and business partners. encouraging interaction with other organisations in a spirit of Open Innovation. It is the single largest investment ever made by the Welsh Government on any university campus. The ILS advances medical science through multi- and inter-disciplinary research and innovation for the benefit of human health, and links those benefits to the economy by ilsinnovation@swansea.ac.uk. To learn more about the Opportunities for health & life science innovation & collaboration in South West Wales, please visit: www.swansea.ac.uk/medicine/ilsinnovation or email Swansea University Medical School, through its Institute of Life Science, is committed to partnerships with academia, NHS and the private and public sector bodies to build on the region s strengths and tackle challenges we are currently facing in healthcare and life sciences. - PROFESSOR KEITH LLOYD Dean and Head of Swansea University Medical School, Swansea University Swansea University Medical School 1
OBJECTIVES The aim of the Executive Round Table and this summary document is to: Foster collaboration Identify opportunities for collaboration within the Health & Life Science sectors in South West Wales Improve the health and wellbeing of the population Accelerate the growth of a vibrant sustainable and diverse economy. South West Wales has the perfect environment to lead and succeed on innovation thanks to programmes such as ARCH and existing partnerships with Swansea University. This creates a unique and powerful stakeholder group that presents a solid picture that encourages private investment - JOE DURAN Director Health, Analytics and Performance Computing Fujitsu 2
OUR RANKINGS AND PARTNERS TOP 3 UK MEDICAL SCHOOL The Complete University Guide 2018 2ND IN UK FOR RESEARCH QUALITY Research Excellence Framework 2014 1ST IN THE UK FOR RESEARCH ENVIRONMENT Research Excellence Framework 2014 The region has a strong history of collaboration between local authorities and partners. ARCH is further proof of the region s efforts to improve the health and wealth of South West Wales through collaboration and innovation. - PROFESSOR MARC CLEMENT Dean of School of Management & Executive Chair of the, Swansea University Swansea University Medical School 3
KEYNOTE SUMMARY The event s guest speakers provided an outline of the life science sector from their perspective to help inform the roundtable discussions; Professor Marc Clement (Dean of School of Management & Executive Chair of the Institute of Life Science, Swansea University) Professor Hamish Laing (Executive Medical Director and Chief Information Officer and Board Lead for Research and Innovation) Joe Duran (Director for Health, Analytics and Performance Computing at Fujitsu) Professor Marc Clement described some of the incredible outcomes of Institute of Life Science collaborations that have been achieved within the region since the last round table event and the opportunities of the 1.3billion Swansea Bay City Deal (SBCD). The SBCD is the largest ever investment in the South West Wales region. The City Deal brings together national and local government, the NHS, Higher Education and industry. The City Deal aims to transform the economic landscape of the area through investment in high-spec digital infrastructure and world-class facilities in the fields of health and life science innovation, energy and smart manufacturing, stimulating the creation of nearly 10,000 new jobs and increase the value of goods and services (GVA) in the region by 1.8billion. As part of the Swansea Bay City Deal ambitions, the ARCH programme (A Regional Collaboration for Health) is working to address the challenges faced across the region in health and life science through improving Skills, Wellbeing, Innovation and Economic Opportunity. ARCH has successfully delivered to date: Wales first Fujitsu Innovation Hub A bespoke Further Education Talent Bank for young people to develop life sciences careers A Non-Surgical Cancer Strategy Progression of the Life Science & Wellbeing Village in Delta Lakes Development of the ILS@Morriston and ILS HTIC@Singleton through Life Science and Wellbeing Campuses project to support development and innovation of the life science sector These projects are paramount to strengthen the region s capacity to commercialise research, attract additional inward investment and further increase the export of high value goods and services. 4
Professor Hamish Laing provided representatives with an overview in innovation in healthcare. The NHS is facing big challenges that need to be tackled by educating the workforce for the future, introducing new technologies and promoting innovation in care. The ARCH project was established to tackle the healthcare challenges faced by the region. Delivering for a population in-excess of 1million people, ARCH aims to create a healthcare system fit for the 21 st Century, and partnerships between Swansea University Medical School, the Joint Clinical Reseach Facility (JCRF) and the Cancer Research Centre have proved vital to achieving this. Joe Duran concluded the keynote speeches by giving delegates an insight into the development of an Innovation Framework and the opportunities and challenges of innovation in South West Wales. The region has the perfect environment to lead and succeed on innovation thanks to programmes such as ARCH, partnerships between Swansea University Medical School, ABMU, Hywel Dda, local and national government, and organisations such as the Bevan Commission and Morgan Academy. Together he said; these relationships create a unique and powerful stakeholder group that present a solid foundation for investment, reducing risk for private sector collaborations and investments. Similarly ABMU s Patients Know Best (PKB) project uses digital technology to deliver a world first; a system which allows patients to control and share their medical and health records. PKB enables patients to receive and share information online about their health and wellbeing, communicate by audio, video, secure email and messaging, participate in peer-topeer support groups, in trials, and in healthcare decision-making with their clinicians. Healthcare teams can use this to become more data-driven and evidence-based, with a robust and ever-expanding decision-support capability. This digital transformation has the capacity to revolutionise healthcare delivery especially in rural areas. South West Wales has dominant attributes that could make the region an innovator pioneer to meet both urban and rural needs. These, among others, represent the reasons why Fujitsu continue to work and invest in Wales. Co-creation, partnerships and joint outcomes have proved to be the best vehicle to tackle the health and innovation challenges faced by South West Wales and beyond. Programmes such as Accelerate, aimed at creating an innovation platform for Wales, aim to realise Wales unique advantages of scale and integration. There are greater levels of innovation than there were 5 years ago and we are working hard to create a more coherent, national system for healthcare innovation across Wales. - THOMAS JAMES Head of Innovation and Industry Engagement, Welsh Government Swansea University Medical School 5
FOLLOW-UP Participants were asked to note their individual perspectives on the opportunities and challenges for Health and Life Science innovation and collaboration in the region, informed by comments made by the keynote speakers (outlined in pages 4 and 5). Each group noted themes of the discussions and provided feedback to the room. The main discussion points from their feedback are outlined in the below table. 1 OPPORTUNITIES The development of a health passport for every person in South West Wales. This will be different from health records as the information will be public, digitised and owned by the patients. 2 Start tracking greater information throughout a patient s life with a Digital Red Book. 3 4 5 6 7 All services connected to one dashboard which is intuitive and dynamic. Citizen Portal will be remote, mobile and local and will provide true health and wellness insight to both clinicians and patients. Create Active Data which is relevant by giving ownership to individuals to add more information and empower individuals to allow access to broader audiences when and where it may benefit them. The use of current services to create a Knowledge Based Industry. Additionally, consider the possibility of utilising other smart approaches such as alternative energy income to provide offset funding for local services. The possibility of Reprovisioned Local Services to provide a spectrum of responses and interactions. For example; the cross linking of ambulance, transport and fire services in more remote communities to provide a better and faster response Rural areas represent both an opportunity to test innovation and a challenge due to the internet pockets. 8 South West Wales represents a good opportunity for private investment. Due to the current situation of clinicians and the lack of time, the creation of a new role is required 9 to foster innovation. Innovation Champions will facilitate and manage the innovation as well as empower people at the front line to innovate. 10 The development of an Integrated Innovation System and Accelerate - development of innovation infrastructure 11 Hold a Private Sector Hack. 12 Patient Portal (Patients Know Best PKB). ABMU has launched a unique patient-controlled medical records systems. This is an innovative medical record system which gives patients control of their health data. 13 South West Wales has an ambitious vision. 14 Number and variety of Health Boards and Local Authorities being able to adapt health systems to different communities. 6
CHALLENGES Acceptance and change of mind-set from practice to patients updating and sharing their own information with third parties. Personal and institutional investment and buy in needed. The connection of different services that input information onto the Citizen Portal to actually deliver value. Due to Data Protection Principles, it is difficult to empower individuals to share their information. Cross management of Health and Energy budgets is very difficult to realise in complex stakeholder eco system. Employees will require training on the different services they will be providing outside their current roles resulting in a more complex management of risks. South West Wales suffers the lack of private investment and funding to increase the depth and breadth of the innovation system. Innovative ways of sharing resources are required. Due to the current situation of clinicians lack of time, the R&D at their level is very low. There is a lack of support for innovation structure. South West Wales requires more projects dedicated to the creation of an innovation platform within the region. Insufficient funding from Government. In order to foster and empower innovation within the NHS, dedicated hours for research, development and innovation need to be incorporated within the clinicians working hours. The creation of new roles Innovation Champions along with the allocated hours will facilitate innovation within in the NHS. The breadth and depth of the R&D budgets is very small compared to private sector. Information sharing people still working in silos. Attracting expertise from outside Wales, importing the most promising best practices or technology for evaluation. Swansea University Medical School 7
OUTCOMES Based on the survey analysis, the two most voted outcomes out of the 11 opportunities identified are: Integrated innovation system development South West Wales requires the development of an integrated innovation system to tackle the pressing health and wellbeing challenges being faced by the region. Collaboration between academia, NHS and private and public sector, will allow quicker and more efficient solutions to be developed to overcome the current and complex challenges. The integrated innovation system will simultaneously avoid the replication of innovation thus highlighting the synergies that can be realised by a joint approach. Private Sector Hack The pressing healthcare challenges being faced by the region require immediate action. A hack event driven and facilitated by the private sector will bring together and allow collaboration between academia, NHS and private and public sectors with the purpose of initiating and elaborating on solutions. With market demand these can be further developed and applied to improve the health and wellbeing of the South West Wales population and beyond. Furthermore it will be the first step to change a culture of people working in silos whilst creating a culture of healthcare and digital innovators within the health industry. 8 Collaboration between the NHS, academia, industry and independent organisations such as the Bevan Commission is crucial at a time when the status quo is untenable. We must work jointly to find regional and innovative solutions to the enduring challenges facing the NHS and our economy. - Helen Howson Director, Bevan Commission
ENTERPRISE AND INNOVATION TEAM For any further information or enquriries about Enterprise and Innovation at Swansea University Medical School please contact ILS Innovation: Swansea University Medical School Singleton Park SWANSEA SA2 8PP Wales, UK +44 (0) 1792 513718 ilsinnovation@swansea.ac.uk Digital transformation is vital for the future of the NHS - PROFESSOR HAMISH LAING Executive Medical Director and CIO Board lead for Research and Innovation, Abertawe Bro Morgannwg University Health Board Swansea University Medical School 9
TOP 3 UK MEDICAL SCHOOL The Complete University Guide 2018 2ND IN UK FOR RESEARCH QUALITY Research Excellence Framework 2014 1ST IN THE UK FOR RESEARCH ENVIRONMENT Research Excellence Framework 2014 Swansea University Medical School Singleton Park SWANSEA SA2 8PP Wales, UK +44 (0) 1792 513718 ilsinnovation@swansea.ac.uk SwanseaMedicine www.swansea.ac.uk/medicine/ilsinnovation